Company Filing History:
Years Active: 2012-2022
Title: Innovations by Bjorg Kristjansdottir in Ovarian Cancer Diagnostics
Introduction
Bjorg Kristjansdottir is an accomplished inventor based in Gothenburg, Sweden. He has made significant contributions to the field of ovarian cancer diagnostics, holding two patents that focus on innovative diagnostic tests. His work aims to improve the clinical management of ovarian cysts and cancers, providing valuable tools for healthcare professionals.
Latest Patents
One of Kristjansdottir's latest patents is a diagnostic test for ovarian cysts, which is based on the detection of mutations characteristic of the most common neoplasms associated with these lesions. This test successfully identified tumor-specific mutations in the cyst fluids of 79% of borderline tumors and 90% of malignant ovarian cancers. Notably, no mutations were detected in the cyst fluids from non-neoplastic cysts and benign tumors. The test demonstrated a sensitivity of 85% and a specificity of 100%, indicating its potential to inform the diagnosis of ovarian cysts effectively.
Another significant patent involves methods for diagnosing ovarian cancer through the use of protein-based biomarkers. These biomarkers are instrumental in classifying a subject's sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease, or other malignant conditions. The biomarkers can be detected using techniques such as SELDI mass spectrometry and immunoassay, showcasing the versatility of this diagnostic approach.
Career Highlights
Throughout his career, Kristjansdottir has worked with prestigious institutions, including The Johns Hopkins University and Vermillion Corporation. His experience in these organizations has contributed to his expertise in the field of cancer diagnostics and has facilitated the development of his innovative patents.
Collaborations
Kristjansdottir has collaborated with notable colleagues, including Karin Sundfeldt and Yuxuan Wang. These partnerships have likely enriched his research and contributed to the advancements in ovarian cancer diagnostics.
Conclusion
Bjorg Kristjansdottir's contributions to ovarian cancer diagnostics through his innovative patents highlight the importance of research in improving patient outcomes. His work continues to pave the way for advancements in the field, ultimately benefiting women affected by ovarian cysts and cancers.